You're going to hear more about "aspirin resistance

May 2003

You're going to hear more about "aspirin resistance."

Tests suggest that about 10% of patients are resistant to aspirin's antiplatelet effects...and therefore might not benefit from using low-dose aspirin to prevent cardiovascular disease.

Now a study suggests that these patients are up to 3 times more likely to die of cardiovascular disease.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote